From Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal:

Kendall Square

Kendall Square—

Photo by Flickr user Dan4th Nicholas.

Used under Creative Commons license creativecommons.org/licenses/by/2.0

Cropped to Xconomy standard.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Webinar
Aug. 19 – Next-Generation Drug Discovery: Leveraging E3 Ligases for Targeted Protein Degradation
This new paradigm may well define a next dimension of precision medicine
Eurofins Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!